Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1614 1628
This examiner grants 26% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17852032 | IONIC LIQUIDS FOR INTERNAL DELIVERY | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17715447 | COMPOSITION OF AZELAIC ACID HAVING ADIPOSE TRIGLYCERIDE HYDROLYSIS EFFECT | Final Rejection | Korea University Research and Business Foundation |
| 17614267 | COMPOSITION AND METHOD FOR ENHANCING SPORE GERMINATION AND BIOLOGICAL EFFICACY | Final Rejection | DANSTAR FERMENT AG |
| 18581659 | METHOD OF TREATING ALZHEIMER'S DISEASE | Non-Final OA | Vector Vitale IP LLC |
| 17064443 | COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF OBESITY | Final Rejection | Vector Vitale IP LLC |
| 17633973 | ENZYME INHIBITORS | Non-Final OA | KALVISTA PHARMACEUTICALS LIMITED |
| 17921540 | SOLID AND LIQUISOLID FORMULATIONS OF CORALLOPYRONIN A | Final Rejection | RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN |
| 16973986 | BIO-HERBICIDE BASED ON ESSENTIAL OIL | Non-Final OA | Université de Liège |
| 18106084 | COMPOSITIONS AND METHODS FOR TREATING PAIN AND/OR INFLAMMATION | Non-Final OA | Neumentum, Inc. |
| 17937778 | RADIATION SENSITIVITY ENHANCING COMOPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | Non-Final OA | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES |
| 17050462 | RADIATION SENSITIVITY ENHANCING COMPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | Final Rejection | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES |
| 17791700 | METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A DIPEPTIDYL PEPTIDASE 4 INHIBITOR | Non-Final OA | Resverlogix Corp. |
| 17917608 | COMPOSITION COMPRISING RESVERATROL | Final Rejection | GALENUS G.H. AG |
| 17995220 | THE USE OF DIFFUSION ENHANCING COMPOUNDS FOR TREATMENT OF VIRAL AND BACTERIAL INDUCED RESPIRATORY DISEASE | Non-Final OA | DIFFUSION PHARMACEUTICALS LLC |
| 17792863 | TOPICAL FORMULATION CONTAINING RAPAMYCIN | Final Rejection | NOBELPHARMA CO., LTD. |
| 17781006 | HIGH-STRENGTH MEDICAL FIBER COMPOSITE MATERIAL | Non-Final OA | CHANGZHOU INSTITUTE OF TECHNOLOGY |
| 17520763 | Photosensitive Dyes and Method of Using Said Dyes | Final Rejection | STRT LLC |
| 17279555 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NITM AND MEDICAL USE THEREOF | Final Rejection | SHENYANG XiNGQi PHARMACEUTICAL CO., LTD. |
| 16967990 | NOVEL PAENIBACILLUS POLYMYXA AND USES THEREOF | Final Rejection | VALAGRO S.P.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy